Pure Global
NCT04182009

A Comparison of Two Nebulisers for Sputum Induction

A Comparison of Two Nebulisers for Performing Sputum Induction to Assess Airway Inflammation
University of Nottingham·ClinicalTrials.gov·device·Device trial
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Asthma,COPD
Drug/Device/Intervention
Omron NE-U17 Ultrasonic nebuliser
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
University of Nottingham
Location
Nottingham, United Kingdom
Timeline & enrollment
Phase
N/A
Start date
Sep 17, 2018
End date
Dec 31, 2019
Enrollment
54 participants
Primary outcome

The tolerability to sputum induction test

Summary

Sputum induction is considered a relatively non-invasive, reliable procedure, which can be
 utilised to characterise the inflammatory profile of the airways.
 
 However, the procedure can be slightly uncomfortable for patients. This study aims to assess
 the differences in participants' tolerability of sputum induction, by comparing two different
 nebulisers when performing the procedure.

ICD-10 classifications
AsthmaAsthma, unspecifiedNonallergic asthmaMixed asthmaOther chronic obstructive pulmonary disease
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04182009
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT04182009 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Nottingham and is currently status unknown. The study focuses on Asthma,COPD. Target enrollment is 54 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.